Back to News
Market Impact: 0.15
Barclays Initiates Coverage of Insulet with Equal-Weight Rating
Source: Nasdaq
Analyst Insights
Barclays initiated coverage of Insulet on October 7, 2026, with an Equal-Weight recommendation. The article notes that Barclays had maintained an Underweight rating on May 8, 2026; it provides no price target or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Susquehanna raises Marvell stock price target on data center growth
- Cantor Fitzgerald lowers Arthur J. Gallagher price target on EPS cuts
- W P Carey stock hits 52-week low at 63.08 USD
- European bank shares fall as bond yields surge, spreads widen
- Exclusive: Meet the 38-year-old founder who left Wall Street for love and created an AI insurance unicorn a decade later
- Existential threats join bubble fears as AI mood sobers at Singapore forums
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)
- AI for M&A Target Screening: From Universe to Deal File